X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (60295) 60295
Newspaper Article (5423) 5423
Newsletter (1453) 1453
Web Resource (517) 517
Book Chapter (366) 366
Dissertation (179) 179
Magazine Article (150) 150
Conference Proceeding (97) 97
Publication (42) 42
Book / eBook (38) 38
Trade Publication Article (27) 27
Reference (20) 20
Book Review (6) 6
Government Document (6) 6
Transcript (4) 4
Journal / eJournal (1) 1
Paper (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25702) 25702
animals (23839) 23839
male (19696) 19696
bile (17005) 17005
female (12750) 12750
rats (11697) 11697
bile acids (9701) 9701
bile acids and salts - metabolism (9023) 9023
liver (8519) 8519
gastroenterology & hepatology (7258) 7258
adult (6746) 6746
middle aged (6714) 6714
liver - metabolism (6527) 6527
mice (5325) 5325
biochemistry & molecular biology (5324) 5324
acids (5136) 5136
cholesterol (5026) 5026
bile - metabolism (4987) 4987
metabolism (4825) 4825
research (4775) 4775
aged (4457) 4457
bile-acids (4359) 4359
pharmacology & pharmacy (4356) 4356
liver diseases (4164) 4164
cholesterol - metabolism (3556) 3556
expression (3242) 3242
analysis (3184) 3184
bile acids and salts - pharmacology (3175) 3175
surgery (3099) 3099
rodents (3029) 3029
physiological aspects (2892) 2892
proteins (2876) 2876
cholestasis (2870) 2870
bile acids and salts - analysis (2862) 2862
liver - drug effects (2660) 2660
time factors (2603) 2603
rats, sprague-dawley (2461) 2461
bile acids and salts (2437) 2437
bile acids and salts - blood (2437) 2437
gene expression (2350) 2350
cancer (2306) 2306
lipids (2269) 2269
deoxycholic acid (2234) 2234
bile acid (2218) 2218
kinetics (2218) 2218
ursodeoxycholic acid (2217) 2217
diet (2198) 2198
oncology (2156) 2156
physiology (2155) 2155
lipid metabolism (2136) 2136
research article (2086) 2086
hydrogen-ion concentration (2070) 2070
liver - pathology (2040) 2040
disease (2016) 2016
salts (1992) 1992
inflammation (1976) 1976
health aspects (1939) 1939
medicine (1911) 1911
rats, wistar (1852) 1852
gastroenterology (1837) 1837
nutrition & dietetics (1818) 1818
cholesterol - blood (1814) 1814
dogs (1811) 1811
microbiology (1808) 1808
cell biology (1783) 1783
identification (1779) 1779
rats, inbred strains (1775) 1775
digestive system (1736) 1736
medicine, research & experimental (1725) 1725
bacteria (1723) 1723
multidisciplinary sciences (1723) 1723
risk factors (1711) 1711
bile - analysis (1704) 1704
enzymes (1684) 1684
disease models, animal (1683) 1683
gastroenterology and hepatology (1671) 1671
metabolites (1671) 1671
apoptosis (1669) 1669
in vitro techniques (1654) 1654
pediatrics (1618) 1618
hepatocytes (1590) 1590
intestinal absorption (1570) 1570
gallbladder diseases (1533) 1533
toxicology (1518) 1518
mice, inbred c57bl (1499) 1499
chemistry (1493) 1493
bile - chemistry (1490) 1490
medicine & public health (1482) 1482
activation (1477) 1477
homeostasis (1465) 1465
endocrinology & metabolism (1445) 1445
mass spectrometry (1435) 1435
adolescent (1434) 1434
microbiota (1427) 1427
bile acids and salts - chemistry (1424) 1424
diagnosis (1417) 1417
bile-acid (1389) 1389
absorption (1388) 1388
cells, cultured (1382) 1382
patients (1382) 1382
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Gerstein Science - Theses (2) 2
Online Resources - Online (2) 2
University Archives - Archives (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Online (1) 1
St Josephs Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (64876) 64876
Japanese (1400) 1400
German (1025) 1025
Russian (742) 742
French (656) 656
Chinese (313) 313
Italian (265) 265
Spanish (233) 233
Polish (126) 126
Korean (89) 89
Portuguese (81) 81
Czech (58) 58
Ukrainian (51) 51
Dutch (37) 37
Hungarian (20) 20
Danish (18) 18
Norwegian (17) 17
Serbian (15) 15
Turkish (15) 15
Swedish (13) 13
Bulgarian (10) 10
Romanian (10) 10
Croatian (9) 9
Finnish (7) 7
Slovak (5) 5
Persian (4) 4
Hebrew (3) 3
Belarusian (2) 2
Arabic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
[Display omitted] Bile acids (BAs) are major regulators of hepatic BA and lipid metabolism but their mechanisms of action in non-alcoholic fatty liver disease (NAFLD... 
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | FXR | NONALCOHOLIC STEATOHEPATITIS | AGONISTS | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | FEEDBACK-REGULATION | LIVER | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | ADIPOSE-TISSUE | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | Gastroenterology & Hepatology | Endokrinologi och diabetes | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | Endocrinology and Diabetes
Journal Article
Journal of hepatology, ISSN 0168-8278, 2013, Volume 58, Issue 1, pp. 155 - 168
Summary Bile acid (BA) transporters are critical for maintenance of the enterohepatic BA circulation where BAs exert their multiple physiological functions including stimulation of bile flow, intestinal absorption... 
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | RAT-LIVER | SALT EXPORT PUMP | GROWTH-FACTOR 19 | ORGANIC ANION TRANSPORTERS | 90-PERCENT PARTIAL-HEPATECTOMY | URSODEOXYCHOLIC ACID | PRIMARY BILIARY-CIRRHOSIS | FARNESOID-X-RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | PHOSPHOLIPID-ASSOCIATED CHOLELITHIASIS | FAMILIAL INTRAHEPATIC CHOLESTASIS | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Journal of lipid research, ISSN 1539-7262, 2017, Volume 58, Issue 6, pp. 1143 - 1152
Journal Article
The American journal of clinical nutrition, ISSN 1938-3207, 2019, Volume 110, Issue 2, pp. 305 - 315
Background: Direct comparisons between SFAs varying in chain length, specifically palmitic acid (16: 0) and stearic acid (18: 0... 
stearic acid | BLOOD-LIPIDS | CHOLESTEROL | lipoprotein | LINOLEIC-ACID | oleic acid | SATURATED FATTY-ACIDS | palmitic acid | coagulation | lipid | cardiometabolic risk factors | secondary bile acids | POSTPRANDIAL LIPEMIA | NUTRITION & DIETETICS | PLASMA-LIPIDS | inflammation | immune response | CORONARY RISK | RICH DIET | VII COAGULANT ACTIVITY | LIPOPROTEINS | Stearic Acids - administration & dosage | Hypercholesterolemia - diet therapy | Palmitic Acid - pharmacology | Oleic Acid - administration & dosage | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Bile Acids and Salts - chemistry | Palmitic Acid - administration & dosage | Bile Acids and Salts - metabolism | Cross-Over Studies | Inflammation - diet therapy | Oleic Acid - pharmacology | Feces - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aged | Stearic Acids - pharmacology | Lipoproteins (low density) | E protein | Coagulation | Washouts | Lymphocytes T | Hydrophobicity | Palmitic acid | Risk factors | Randomization | Lymphocytes | Intestine | Oleic acid | Stearic acid | Lipoproteins (high density) | Immune system | Carbohydrates | Fasting | Immune response | Health risks | Risk analysis | Low density lipoprotein | Cholesterol | Post-menopause | Deoxycholic acid | Acids | Diet | Bile | Cardiometabolic risk factors | Inflammation | Lipoprotein | Secondary bile acids | Lipid
Journal Article
The American journal of clinical nutrition, ISSN 1938-3207, 2019, Volume 109, Issue 5, pp. 1239 - 1250
Background: Replacing dietary saturated fatty acids (SFAs) with polyunsaturated fatty acids (PUFA... 
Metabolic profiling | Nutrition | Cardiovascular risk factors | Tryptophan | Acylcarnitines | Gene expression | Lipoprotein subclasses | Fatty acids | PLASMA ACYLCARNITINES | EVENTS | fatty acids | lipoprotein subclasses | CHOLESTEROL | ACIDS | RISK | cardiovascular risk factors | GUINEA-PIG | metabolic profiling | LDL RECEPTOR PROTEIN | nutrition | NUTRITION & DIETETICS | SERUM-LIPIDS | CARDIOVASCULAR-DISEASE | CORONARY-HEART-DISEASE | acylcarnitines | tryptophan | gene expression | Hypercholesterolemia - diet therapy | Amino Acids - blood | Bile Acids and Salts - blood | Peptide Hydrolases - genetics | Humans | Middle Aged | Fatty Acids, Unsaturated - therapeutic use | Male | Dietary Fats - pharmacology | Dietary Fats - administration & dosage | Fatty Acids - administration & dosage | Cholesterol, LDL - blood | Female | Fatty Acids - blood | Acetic Acid - blood | Peptide Hydrolases - metabolism | Dietary Fats - adverse effects | Double-Blind Method | Acetoacetates - blood | Fatty Acids, Unsaturated - pharmacology | Feeding Behavior | Gene Expression Profiling - methods | Dietary Fats - blood | Lipoproteins - blood | Metabolomics - methods | Fatty Acids, Unsaturated - blood | Diet | Metabolome - drug effects | Lipid Metabolism - drug effects | Hypercholesterolemia - genetics | Hypercholesterolemia - metabolism | Fatty Acids - pharmacology | Fatty Acids, Unsaturated - administration & dosage | Intervention | Lipoproteins (low density) | Mitochondrial uncoupling protein 2 | Metabolomics | Nuclear magnetic resonance--NMR | Profiling | Polyunsaturated fatty acids | Genes | Amino acids | Leukocytes (mononuclear) | Blood | Biological effects | Randomization | Alterations | Peripheral blood mononuclear cells | Lipoprotein (low density) receptors | Discriminant analysis | Bile acids | Liver X receptors | Health risks | Mass spectroscopy | Subtilisin | Metabolism | Cholesterol | Polymerase chain reaction | Hypercholesterolemia | Kexin | Technology assessment | Biomarkers | Oils & fats | Peroxisome proliferator-activated receptors | Cardiovascular diseases | Acetic acid | Mass spectrometry | Original Research Communications
Journal Article